AI assistant
Tinkerine Studios Ltd. — AGM Information 2021
Oct 30, 2021
46344_rns_2021-10-29_aa3f9493-a1ae-4927-a8a1-738a99d06849.pdf
AGM Information
Open in viewerOpens in your device viewer
==> picture [310 x 47] intentionally omitted <==
TINKERINE STUDIOS LTD. Unit 213A, 8275 – 92nd Street Delta, British Columbia V4G 0A4 Telephone: 604.288.8778
NOTICE OF ANNUAL GENERAL MEETING
TAKE NOTICE that an in-person/telephone conference annual general meeting (the “ Meeting ”) of the shareholders of Tinkerine Studios Ltd. (the “ Company ”) will be held at Suite 1500, 1055 West Georgia Street, Vancouver, British Columbia, Canada V6E 4N7 on November 25, 2021 at 10:00 a.m., local time, (the “ Notice ”).
Due to ongoing concerns related to the current coronavirus pandemic (“COVID-19”), and in order to mitigate potential risks to the health and safety of the Company’s shareholders, employees and other stakeholders, shareholders are encouraged not to attend the Meeting in person. The Company is offering Shareholders the option to listen and participate (but not vote) at the Meeting in real time by conference call as follows:
Dial by your location
Canada Toll Free: 1-855-244-8677 Canada Toll: 1-416-915-6530 US Toll Free: 1-855-282-6330 US Toll: 1-415-655-0002 Access Code: 2633 180 9258
At the date of this Notice and the accompanying Information Circular it is the intention of the Company to hold the Meeting at the location stated above in this Notice. We are continuously monitoring development of the current coronavirus (COVID-19) outbreak (“ COVID-19 ”). In light of the rapidly evolving public health guidelines related to COVID-19, we ask shareholders to consider voting their shares by proxy and not attend the meeting in person. Those shareholders who do wish to attend the Meeting in person, should carefully consider and follow the - instructions of the federal Public Health Agency of Canada available at: https://www.canada.ca/en/public health/services/diseases/coronavirus-disease-covid-19.html. We ask that shareholders also review and follow the instructions of any regional health authorities of the Province of British Columbia, including the Vancouver Coastal Health Authority, the Fraser Health Authority and any other health authority holding jurisdiction over the areas you must travel through to attend the Meeting. Do not attend the Meeting in person if you are experiencing any cold or flu-like symptoms, or if you or someone with whom you have been in close contact has travelled to/from outside of Canada within the 14 days immediately prior to the Meeting. All shareholders are strongly encouraged to vote by submitting their completed form of proxy (or voting instruction form) prior to the Meeting by one of the means described in the Information Circular accompanying this Notice.
The Company reserves the right to take any additional precautionary measures deemed to be appropriate, necessary or advisable in relation to the Meeting in response to further developments in the COVID-19 outbreak, including: (i) holding the Meeting virtually or by providing a webcast of the Meeting; (ii) hosting the Meeting solely by means of remote communication; (iii) changing the Meeting date and/or changing the means of holding the Meeting; (iv) denying access to persons who exhibit cold or flu-like symptoms, or who have, or have been in close contact with someone who has, travelled to/from outside of Canada within the 14 days immediately prior to the Meeting; (v) denying access to persons that do not have evidence of full vaccination or a negative COVID-19 rapid test result completed within 24 hours immediately prior to the Meeting, and (vi) such other measures as may be recommended by public health authorities in connection with gatherings of persons such as the Meeting. Should any such changes to the Meeting format occur, the Company will announce any and all of these changes by way of news release, which will be filed under the Company’s profile on SEDAR. We strongly recommend you check the Company’s SEDAR profile prior to the Meeting for the most current information. In the event of any changes to the Meeting format due to the COVID-19 outbreak, the Company will not prepare or mail amended Meeting Proxy Materials.
DUE TO THE COVID-19 VIRUS, WE ARE REQUESTING THAT ALL SHAREHOLDERS VOTE THEIR SHARES BY PROXY AND AVOID ATTENDING THE MEETING IN PERSON
Shareholders who intend to attend the meeting via telephone conference must submit votes by Proxy ahead of the proxy deadline of 10:00 a.m., local time, on Tuesday, November 23, 2021. Attendance by telephone conference allows Shareholders to listen to, but not to vote at, the Meeting.
- 1 -
The Meeting is to be held for the following purposes:
-
to receive and consider the audited consolidated financial statements of the Company for its financial year ended December 31, 2020, together with the auditor’s report thereon;
-
to set the number of directors of the Company for the ensuing year at four persons;
-
to elect directors of the Company for the ensuing year;
-
to appoint Dale Matheson Carr-Hilton LaBonte LLP, Chartered Accountants, as the auditors of the Company for the ensuing year at a remuneration to be fixed by the Board;
-
to consider any amendment to or variation of a matter identified in this Notice; and
-
to transact such other business as may properly come before the Meeting or adjournments thereof.
DATED at Delta, British Columbia, on October 27, 2021.
By Order of the Board of Directors of Tinkerine Studios Ltd.
(signed) “Eugene Suyu”
Eugene Suyu Chief Executive Officer
- 2 -